|
Apr 16
|
DSMB recommends continuation of BioCardia’s cell therapy trial for heart failure
|
|
Apr 15
|
BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial
|
|
Apr 14
|
Emory begins enrolment for BioCardia’s trial of ischemic heart failure therapy
|
|
Apr 11
|
BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study
|
|
Mar 10
|
BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System
|
|
Feb 27
|
BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions
|
|
Oct 9
|
BioCardia Inc (BCDA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
|
|
Sep 18
|
BioCardia Regains Full Compliance with Nasdaq Listing Requirements
|
|
Aug 7
|
BioCardia to Host Q2 2024 Corporate Update and Financial Results Conference Call on August 13, 2024
|
|
Jul 30
|
BioCardia Submits for FDA Approval of Morph® DNA™ Steerable Introducer Product Family
|
|
Jul 25
|
Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure
|
|
May 21
|
BioCardia Announces Reverse Stock Split
|
|
May 15
|
BioCardia Inc (BCDA) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress Amid ...
|
|
May 14
|
BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
|
|
May 14
|
Most Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is Reasonable
|
|
May 9
|
BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024
|
|
May 1
|
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
|
|
Apr 25
|
BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
|
|
Apr 2
|
Insiders Are Buying These 11 Penny Stocks
|
|
Apr 1
|
BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript
|